| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000015477 |
| Receipt No. | R000017478 |
| Scientific Title | A study of the effect of the self-care support program created by nurses in order to enhance diet satisfaction for chemotherapy patients with breast cancer who suffer from taste alteration |
| Date of disclosure of the study information | 2014/10/21 |
| Last modified on | 2019/06/02 (Ver. 8) |
| Basic information | ||
| Public title | A study of the effect of the self-care support program created by nurses in order to enhance diet satisfaction for chemotherapy patients with breast cancer who suffer from taste alteration | |
| Acronym | A study of the effect of the self-care support program created by nurses in order to enhance diet satisfaction for chemotherapy patients with breast cancer who suffer from taste alteration | |
| Scientific Title | A study of the effect of the self-care support program created by nurses in order to enhance diet satisfaction for chemotherapy patients with breast cancer who suffer from taste alteration | |
| Scientific Title:Acronym | A study of the effect of the self-care support program created by nurses in order to enhance diet satisfaction for chemotherapy patients with breast cancer who suffer from taste alteration | |
| Region |
|
|
| Condition | |||
| Condition | Breast Cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Examination of the effect of the intervention for diet satisfaction for taste alteration associated with the chemotherapy |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The satisfaction level of the diet by the taste alteration |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | The support by the nurse using the brochure about the taste alteration | |
| Interventions/Control_2 | Usually support care by the nurse | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1.The women who were diagnosed as breast cancer newly.
2.20 years of age or over. 3.The patients who receive chemotherapy ( anthracyclines and taxanes)before or after operation. 4.Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1. 5.The patients who do not have taste alteration and oral complication or dysphagia. 6.The patients who agree with the study and do not have communication disorder. |
|||
| Key exclusion criteria | 1.The patients stage 4 with advanced breast cancer or the patients recurrent with breast cancer.
2.The patients who received chemotherapy previously because of cancer treatment. 3.The patients who received radiotherapy to oral cavity or salivary gland previously. 4.The patients who had operation to oral cavity previously. 5.The patients who take a medicine which contains zinc currently or previously because of taste alteration. 6.The patients with serious renal disease(more than serum Cr 2.0mg/dL), or receive dialysis. 7.The patients with serious liver disease. 8.The patients with hepatic disorder, mental disorder, an oral cavity malignant tumor and the diabetes. 9.The patients who have already taken a supplement which contains zinc or a medicine which contains zinc. 10.Patients who are excluded by the doctor's judgment. |
|||
| Target sample size | 150 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Hiroshima University Graduate School of Biomedical & Health Sciences | ||||||
| Division name | Department of Health Care for Adults | ||||||
| Zip code | 734-8553 | ||||||
| Address | 1-2-3 Kasumi, Minamiku-ku, Hiroshima City, Hiroshima prefecture | ||||||
| TEL | 082-257-5383 | ||||||
| ktanae2@hiroshima-u.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Hiroshima University Graduate School of Biomedical & Health Sciences | ||||||
| Division name | Department of Health Care for Adults | ||||||
| Zip code | 734-8553 | ||||||
| Address | 1-2-3 Kasumi, Minamiku-ku, Hiroshima City, Hiroshima prefecture | ||||||
| TEL | 082-257-5383 | ||||||
| Homepage URL | |||||||
| asano-sanae@hiroshima-u.ac.jp | |||||||
| Sponsor | |
| Institute | Hiroshima University Graduate School of Biomedical & Health Sciences |
| Institute | |
| Department | |
| Funding Source | |
| Organization | YAMAJI FUMIKO NURSING RESERACH FUND |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Hiroshima Univercity Hospital |
| Address | 1-2-3 Kasumi, Minamiku-ku, Hiroshima City, Hiroshima prefecture |
| Tel | 082-257-5907 |
| kasumi-kenkyu@office.hiroshima-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 88 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017478 |